CHICAGO—A worsening Kansas City Cardiomyopathy Questionnaire overall summary (KCCQ-OS) score is associated with a higher risk of adverse outcomes in patients with transthyretin-mediated amyloid ...

ROUND ROCK, TX / ACCESS Newswire / March 20, 2025 / TSS, Inc. (NASDAQ:TSSI), a leader in IT hardware and software integration for AI and high-performance computing, will report its 2024 fourth ...

主要终点为全因死亡、心衰事件及KCCQ-TSS评分的改善。该研究将为SGLT2i与MRA联合使用对降低高钾血症风险的潜在益处提供重要数据。 BalanceD-HF是一项 ...

In its fourth quarter 2024 investor letter, Kingdom Capital Advisors emphasized stocks such as TSS, Inc. (NASDAQ:TSSI). TSS, Inc. (NASDAQ:TSSI) is a US-based integration technology services provider.

试验的主要结局是 3 个月后的健康状况，通过堪萨斯城心肌病问卷总体总结评分（KCCQ-OSS）评估。次要结局包括口渴不适和安全事件。在 504 名随机分组的患者（男性占 67.3%）中，自由液体摄入组 3 个月后的 KCCQ-OSS 为 74.0，液体限制组为 72.2，经基线评分调整后的 ...

Additionally, patients under age 70 in the MIH group showed more improvement in health status than those in the TOCC group, where younger patients saw less gain on KCCQ scores than older adults.

Patients showed similar changes in their Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Scores 3 months into the trial whether they had been allowed liberal fluid intake or told ...

The majority of participants (87.1%) had NYHA class II symptoms, and most were taking standard HF medication; 51% were taking loop diuretics. Their median baseline KCCQ Overall Summary Score (KCCQ-OSS ...